Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 36.13 +0.10 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.03 | 52 Week High | $1.35 | |||
| Open | $36.11 | 52 Week Low | $0.10 | |||
| Day High | $37.05 | P/E | N/A | |||
| Day Low | $35.00 | EPS | $0.00 | |||
| Volume | 2,313,566 | |||||
